Study the antipyretic effect of Sarivadi Syrup in school going childre
Phase 2
- Conditions
- Health Condition 1: B349- Viral infection, unspecified
- Registration Number
- CTRI/2023/01/049028
- Lead Sponsor
- DrCharushila Nagawade
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)Children between the age of 6-12 years irrespective of gender and socioeconomic status. **jwara (fever). 3)Children with fever between 37.4°C (99.3°f)to 38.3°C(100.94°f) 4)children suffering from fever for less than
48hr. 5)Children whose parents are ready to participate in the
clinical trial by giving informed written assent.**
Exclusion Criteria
1)Children with fever >38.3°C(100.94°F)
2)Children suffer from Fever for more than 48hr.
3)Children suffering from the common cold, and cough. Vomiting
diarrhea fever with rash and the common conditions
4)K/C/O Systemic illness.
5)Patients with history of Febrile Convulsions
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in axillary temperature of patientTimepoint: 5 days study with 0,3rd and 5th day
- Secondary Outcome Measures
Name Time Method To observe the adverse effect of Sarivadi SyrupTimepoint: 5 days study with 0,3rd and 5th day